Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point Mutation
Clinical trial NCT01074359 · TERMINATED
Trial details
- NCT number
- NCT01074359
- Sponsor
- Penwest Pharmaceuticals Co.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.